Skip to menu Skip to content Skip to footer
Professor

Scott Bell

Email: 

Overview

Availability

Professor Scott Bell is:
Available for supervision

Works

Search Professor Scott Bell’s works on UQ eSpace

424 works between 1991 and 2025

21 - 40 of 424 works

2024

Journal Article

Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis

Blake, Tamara L., Sly, Peter D., Andersen, Isabella, Wainwright, Claire E., Reid, David W., Bell, Scott C., Smith, Briana R., Kettle, Anthony J. and Dickerhof, Nina (2024). Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis. Journal of Cystic Fibrosis, 23 (6), 1163-1166. doi: 10.1016/j.jcf.2024.04.009

Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis

2024

Conference Publication

Mycobacteria acquisition from potable water

Ramsay, K., Smith, K., Carter, R., Clayton, M., Thomson, R. and Bell, S. (2024). Mycobacteria acquisition from potable water. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science,, Gold Coast, QLD, Australia, 22-26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673

Mycobacteria acquisition from potable water

2024

Journal Article

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis

Tarique, Abdullah A., Tuladhar, Neeraj, Kelk, Dean, Begum, Nelufa, Lucas, Richard M., Luo, Lin, Stow, Jennifer L., Wainwright, Claire E., Bell, Scott C., Sly, Peter D. and Fantino, Emmanuelle (2024). Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Cells, 13 (2) 166, 1-13. doi: 10.3390/cells13020166

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis

2024

Journal Article

Standards for the care of people with cystic fibrosis; establishing and maintaining health

Southern, Kevin, Addy, Charlotte, Bell, Scott C., Bevan, Amanda, Borawska, Urzula, Brown, Catherine, Burgel, Pierre-Régis, Button, Brenda, Castellani, Carlo, Chansard, Audrey, Chilvers, Mark, Davies, Gwyneth, Davies, Jane, De Boeck, Kris, Declercq, Dimitri, Doumit, Michael, Drevinek, Pavel, Fajac, Isabelle, Gartner, Silvia, Georgiopoulos, Anna, Gursli, Sandra, Gramegna, Andrea, Hansen, Carina M. E., Hug, Martin, Lammertyn, Elise, Landau, Edwina (Eddie) C., Langley, Ross, Mayer-Hamblett, Nicole, Middleton, Anna ... van Koningsbruggen-Rietschel, Silke (2024). Standards for the care of people with cystic fibrosis; establishing and maintaining health. Journal of Cystic Fibrosis, 23 (1), 12-28. doi: 10.1016/j.jcf.2023.12.002

Standards for the care of people with cystic fibrosis; establishing and maintaining health

2024

Book Chapter

Working with cystic fibrosis

Bell, Scott C., Sufian, Beth S. and Passamano, James A. (2024). Working with cystic fibrosis. Hodson and Geddes’ Cystic Fibrosis. (pp. 465-476) edited by Andrew Bush, Margarida D. Amaral, Jane C. Davies, Nicholas J. Simmonds, Jennifer L. Taylor-Cousar and Sarath C. Ranganathan. Boca Raton, FL, United States: CRC Press. doi: 10.1201/9781003262763-44

Working with cystic fibrosis

2023

Journal Article

Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens

Huang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201

Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens

2023

Journal Article

Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease

Baird, Timothy and Bell, Scott (2023). Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease. Clinics in Chest Medicine, 44 (4), 847-860. doi: 10.1016/j.ccm.2023.06.008

Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease

2023

Journal Article

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas

Evans, Ieuan E. S., Kumar, Shanal, France, Megan, Smith, Daniel, Masel, Philip, Tay, George, Henderson, Daniel, Bell, Scott C. and Reid, David (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. Respirology Case Reports, 11 (12) e01235, 1-4. doi: 10.1002/rcr2.1235

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas

2023

Journal Article

Letter to the editor

Kumar, Shanal and Bell, Scott (2023). Letter to the editor. Bone, 177 116890, 1-2. doi: 10.1016/j.bone.2023.116890

Letter to the editor

2023

Journal Article

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

Burke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

2023

Journal Article

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

Mayer-Hamblett, Nicole, Clancy, John Paul, Jain, Raksha, Donaldson, Scott H., Fajac, Isabelle, Goss, Christopher H., Polineni, Deepika, Ratjen, Felix, Quon, Bradley S., Zemanick, Edith T., Bell, Scott C., Davies, Jane C., Jain, Manu, Konstan, Michael W., Kerper, Natanya R., LaRosa, Tré, Mall, Marcus A., McKone, Edward, Pearson, Kelsie, Pilewski, Joseph M., Quittell, Lynne, Rayment, Jonathan H., Rowe, Steven M., Taylor-Cousar, Jennifer L., Retsch-Bogart, George and Downey, Damian G. (2023). Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective. The Lancet Respiratory Medicine, 11 (10), 932-944. doi: 10.1016/s2213-2600(23)00297-7

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

2023

Journal Article

A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis

Ryan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4

A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis

2023

Journal Article

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex

Ramsay, Kay A., Rehman, Attika, Wardell, Samuel T., Martin, Lois W., Bell, Scott C., Patrick, Wayne M., Winstanley, Craig and Lamont, Iain L. (2023). Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PLoS One, 18 (5) e0285856, 1-14. doi: 10.1371/journal.pone.0285856

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex

2023

Conference Publication

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

2023

Journal Article

Thoracic Society of Australia and New Zealand (TSANZ ) position statement on chronic suppurative lung disease and bronchiectasis in children , adolescents and adults in Australia and New Zealand

Chang, Anne B., Bell, Scott C., Byrnes, Catherine A., Dawkins, Paul, Holland, Anne E., Kennedy, Emma, King, Paul T., Laird, Pamela, Mooney, Sarah, Morgan, Lucy, Parsons, Marianne, Poot, Betty, Toombs, Maree, Torzillo, Paul J. and Grimwood, Keith (2023). Thoracic Society of Australia and New Zealand (TSANZ ) position statement on chronic suppurative lung disease and bronchiectasis in children , adolescents and adults in Australia and New Zealand. Respirology, 28 (4), 339-349. doi: 10.1111/resp.14479

Thoracic Society of Australia and New Zealand (TSANZ ) position statement on chronic suppurative lung disease and bronchiectasis in children , adolescents and adults in Australia and New Zealand

2023

Journal Article

Do tobacco and cannabis use and co-use predict lung function: a longitudinal study

Najman, Jake M., Bell, Scott, Williams, Gail M., Clavarino, Alexandra M., Scott, James G., McGee, Tara R. and Mamun, Abdullah A. (2023). Do tobacco and cannabis use and co-use predict lung function: a longitudinal study. Respiratory Medicine, 208 107124, 107124. doi: 10.1016/j.rmed.2023.107124

Do tobacco and cannabis use and co-use predict lung function: a longitudinal study

2023

Journal Article

Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators

Burke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883

Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators

2023

Journal Article

Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand

Coriati, Adèle, Ma, Xiayi, Sykes, Jenna, Stanojevic, Sanja, Ruseckaite, Rasa, Lemonnier, Lydie, Dehillotte, Clémence, Tate, Jan, Byrnes, Catherine Ann, Bell, Scott C., Burgel, Pierre Regis and Stephenson, Anne L (2023). Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand. Thorax, 78 (3) 219086, 242-248. doi: 10.1136/thorax-2022-219086

Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand

2023

Journal Article

Wave 1 results of the INTerventions, Research, and Action in Cities Team (INTERACT) cohort study: Examining spatio-temporal measures for urban environments and health

Fuller, Daniel, Bell, Scott, Firth, Caislin L., Muhajarine, Nazeem, Nelson, Trisalyn, Stanley, Kevin, Sones, Meridith, Smith, Jefferson, Thierry, Benoit, Laberee, Karen, Stephens, Zoe Poirier, Phillips, Kole, Kestens, Yan and Winters, Meghan (2023). Wave 1 results of the INTerventions, Research, and Action in Cities Team (INTERACT) cohort study: Examining spatio-temporal measures for urban environments and health. Health and Place, 79 102646, 1-9. doi: 10.1016/j.healthplace.2021.102646

Wave 1 results of the INTerventions, Research, and Action in Cities Team (INTERACT) cohort study: Examining spatio-temporal measures for urban environments and health

2022

Journal Article

Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era

Davidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342

Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era

Funding

Current funding

  • 2025 - 2028
    Combating pathogens from biofilms in premise plumbing systems
    ARC Linkage Projects
    Open grant
  • 2023 - 2026
    Making Australia resilient to airborne infection transmission (ARC Linkage Project administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2019 - 2026
    Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMAT)
    Cystic Fibrosis Foundation USA
    Open grant
  • 2019 - 2026
    Queensland cystic fibrosis research program
    The Children's Hospital Foundation
    Open grant
  • 2018 - 2026
    Multi-drug resistant non-tuberculous mycobacteria infection research
    Research Donation Generic
    Open grant

Past funding

  • 2021 - 2023
    Prevention of SARS-CoV-2 transmission in aged care (PETRA formerly PreSTAC): Effective evidence-based measures for rapid translation - External led SAHMRI
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020
    BD Bactec MGIT 320 System
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2023
    The emerging problem of non-tuberculous mycobacteria infection: Understanding aetiology, geospatial epidemiology and developing interventions
    NHMRC Project Grant
    Open grant
  • 2019 - 2024
    Early life origins of cystic fibrosis lung disease
    Cystic Fibrosis Foundation USA
    Open grant
  • 2019
    Establishing UQ Centre for Clinical Research as the centre for Aerosol therapy in critical care by optimising particle size of aerosols for effective drug delivery.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Enhancing detection and management of Mycobacterium abscessus complex (MABSC) infection in children with cystic fibrosis
    The Children's Hospital Foundation
    Open grant
  • 2016 - 2019
    Macrophages: the forgotten cells in CF lung disease
    Cystic Fibrosis Foundation Therapeutics Inc
    Open grant
  • 2016 - 2020
    The acquired resistome of Pseudomonas aeruginosa strains in people with cystic fibrosis (Joint UQ/QIMR AID seed grant awarded to QIMRB)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2019
    The emerging problem of non-tuberculous mycobacteria infection: understanding aetiology, geospatial epidemiology and developing interventions (NHMRC Project led by QIMR Berghofer)
    Queensland Institute of Medical Research
    Open grant
  • 2015 - 2017
    Abnormal lung iron homeostasis in cystic fibrosis (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2014 - 2016
    Intra-strain diversity of Pseudomonas aeruginosa in the lungs of patients with CF and their role in exacerbation
    Prince Charles Hospital Foundation
    Open grant
  • 2013 - 2014
    Purchase of -80C Freezer - XYCYST
    Prince Charles Hospital Foundation
    Open grant
  • 2012 - 2014
    Airborne Infection Transport in Hospitals
    Prince Charles Hospital Foundation
    Open grant
  • 2010 - 2016
    Inflammatory airways disease in children with a focus on cystic fibrosis
    Royal Children's Hospital Foundation
    Open grant
  • 2010 - 2011
    Longitudinal study of clonal Pseudomonas aeruginosa in cystic fibrosis
    Queensland Health
    Open grant
  • 2010 - 2011
    Development of a novel assay for the detection of clonal P.aeruginosa in persons with CF
    Australian Cystic Fibrosis Research Trust
    Open grant
  • 2010 - 2011
    Longitudinal study of clonal Pseudomonas aeruginosa in cystic fibrosis
    Royal Children's Hospital Foundation
    Open grant
  • 2009 - 2015
    A statewide, electronic, disease specific, clinical record/database for children and adults with cystic fibrosis (electronic medical record for cystic fibrosis)
    Royal Children's Hospital Foundation
    Open grant
  • 2007 - 2010
    Clinical impact of clonal Pseudomonas aeruginosa in cystic fibrosis
    NHMRC Project Grant
    Open grant
  • 2005 - 2010
    How Children and adults with cystic fibrosis get lung infections with Pseudomonas aeruginosa
    Royal Children's Hospital Foundation
    Open grant

Supervision

Availability

Professor Scott Bell is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Risk and mitigation of cough aerosols for people with cystic fibrosis.

    Principal Advisor

    Other advisors: Professor Rachel Thomson

  • Doctor Philosophy

    The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis Infection

    Associate Advisor

    Other advisors: Professor Rachel Thomson, Professor Jason Roberts

Completed supervision

Media

Enquiries

For media enquiries about Professor Scott Bell's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au